| Date Checked | 2025-12-21 23:41:12 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | ABSI |
| AssetType | Common Stock |
| Name | Absci Corp |
| Description | None |
| CIK | 1672688 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 18105 SE MILL PLAIN BOULEVARD, VANCOUVER, WA, UNITED STATES, 98683 |
| OfficialSite | https://www.absci.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 508256000 |
| EBITDA | -105502000 |
| PERatio | 0 |
| PEGRatio | None |
| BookValue | 1.405 |
| DividendPerShare | None |
| EPS | -0.91 |
| RevenuePerShareTTM | 0.022 |
| ProfitMargin | 0 |
| OperatingMarginTTM | -79.77 |
| ReturnOnAssetsTTM | -0.306 |
| ReturnOnEquityTTM | -0.557 |
| RevenueTTM | 2815000 |
| GrossProfitTTM | -70233000 |
| DilutedEPSTTM | -0.91 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | -0.778 |
| AnalystTargetPrice | 8.26 |
| AnalystRatingStrongBuy | 3 |
| AnalystRatingBuy | 6 |
| AnalystRatingHold | 0 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | 180.55 |
| PriceToBookRatio | 2.416 |
| EVToRevenue | 128.6 |
| EVToEBITDA | -0.391 |
| Beta | 2.14 |
| 52WeekHigh | 6.33 |
| 52WeekLow | 2.01 |
| 50DayMovingAverage | 3.654 |
| 200DayMovingAverage | 3.053 |
| SharesOutstanding | 150372000 |
| SharesFloat | 132725000 |
| PercentInsiders | 9.283 |
| PercentInstitutions | 66.062 |
| ExDividendDate | None |
| etoro | 1 |
| dateChecked | 2025-12-21 23:41:12 |
| fresh | 1 |